| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
|
Boccia, Ralph V.
|
|
2017
|
17 |
7 |
p. 433-437
5 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2017
|
17 |
7 |
p. A4-
1 p.
|
artikel
|
| 3 |
Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation
|
Kapke, Jonathan T.
|
|
2017
|
17 |
7 |
p. 408-414
7 p.
|
artikel
|
| 4 |
Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients
|
Ren, Yuyue
|
|
2017
|
17 |
7 |
p. 415-423
9 p.
|
artikel
|
| 5 |
Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple Myeloma
|
Voorhees, Peter M.
|
|
2017
|
17 |
7 |
p. 424-432
9 p.
|
artikel
|
| 6 |
Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest
|
Danthala, Madhav
|
|
2017
|
17 |
7 |
p. 457-462
6 p.
|
artikel
|
| 7 |
Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia
|
Srour, Samer A.
|
|
2017
|
17 |
7 |
p. 450-456.e2
45151 p.
|
artikel
|
| 8 |
New Agents in Multiple Myeloma: An Examination of Safety Profiles
|
Bringhen, Sara
|
|
2017
|
17 |
7 |
p. 391-407.e5
4.069961E7 p.
|
artikel
|
| 9 |
Outcome and Clinical Significance of Immunophenotypic Markers Expressed in Different Treatment Protocols of Pediatric Patients With T-ALL in Developing Countries
|
Sayed, Douaa M.
|
|
2017
|
17 |
7 |
p. 443-449
7 p.
|
artikel
|
| 10 |
Table of Contents
|
|
|
2017
|
17 |
7 |
p. A7-A8
nvt p.
|
artikel
|
| 11 |
Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant
|
Dosin, Gilles
|
|
2017
|
17 |
7 |
p. 438-442
5 p.
|
artikel
|
Tijdschrift beschrijving